Immunosuppressive agents enhance the cytokine-induced priming of inflammatory cells

Int Arch Allergy Immunol. 1995 May-Jun;107(1-3):259-60. doi: 10.1159/000236996.

Abstract

The influence of the immunosuppressive substances cyclosporin A (CsA), FK506 and rapamycin on inflammatory mediators from cytokine-primed human leukocytes was studied. The cells were primed with granulocyte/macrophage-colony-stimulating factor, granulocyte-stimulating factor (G-CSF) and interleukin-3 (IL-3), and subsequently stimulated with the chemotactic peptide fMLP. The immunosuppressive agents CsA and FK506 enhanced the release of leukotriene B4 (LTB4) from human neutrophil granulocytes dependent on the priming with G-CSF and IL-3. IL-3-primed neutrophils released up to threefold higher amounts of LTB4 after subsequent stimulation with FK506 and fMLP. In contrast, the immunosuppressant rapamycin inhibited the formation of LTB4 after subsequent stimulation with fMLP. In addition to the well-documented inhibitory effects on lymphocyte function, our results indicate an enhancing effect of the immunosuppressive agents on the cellular inflammatory response of human peripheral blood neutrophils.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Cytokines / pharmacology*
  • Drug Synergism
  • Humans
  • Immunosuppressive Agents / pharmacology*
  • Leukocytes / drug effects*
  • Leukocytes / immunology
  • Leukotriene B4 / metabolism
  • N-Formylmethionine Leucyl-Phenylalanine / pharmacology

Substances

  • Cytokines
  • Immunosuppressive Agents
  • Leukotriene B4
  • N-Formylmethionine Leucyl-Phenylalanine